Literature DB >> 13945311

Antibody formation initiated in vitro. II. Antibody synthesis in x-irradiated recipients of diffusion chambers containing nucleic acid derived from macrophages incubated with antigen.

M FISHMAN, F L ADLER.   

Abstract

The diffusion chamber technique permitted the demonstration of specific antibody formation in x-irradiated recipients of such chambers filled with normal lymph node cells and a cell-free homogenate of macrophages which had been incubated in intro with T2 bacteriophage. The activity of the cell-free homogenate was retained in its RNA fraction isolated by means of the phenol method. No antibody formation occurred if such RNA was treated with RNAase. On sucrose gradients (5 to 20 per cent), the active RNA was found to be present in the top third layer. The question of the possible presence of antigen complexed to the RNA is discussed.

Entities:  

Keywords:  ANTIBODY FORMATION; COLIPHAGES; LYMPH NODES; MACROPHAGES; RADIATION EFFECTS; RNA

Mesh:

Substances:

Year:  1963        PMID: 13945311      PMCID: PMC2137621          DOI: 10.1084/jem.117.4.595

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Influence of ribonucleic acids from the liver on implantation and growth of transplantable tumours.

Authors:  N N AKSENOVA; V M BRESLER; V I VOROBYEV; J M OLENOV
Journal:  Nature       Date:  1962-11-03       Impact factor: 49.962

2.  Antibody formation in tissue culture.

Authors:  M FISHMAN
Journal:  Nature       Date:  1959-04-25       Impact factor: 49.962

3.  Growth of mouse ascites tumor cells in diffusion chambers. I. Studies of growth rate of cells and of the rate of entry of antibody.

Authors:  D B AMOS; J D WAKEFIELD
Journal:  J Natl Cancer Inst       Date:  1958-10       Impact factor: 13.506

4.  Studies of heterografts in diffusion chambers in mice.

Authors:  G H ALGIRE; M L BORDERS; V J EVANS
Journal:  J Natl Cancer Inst       Date:  1958-06       Impact factor: 13.506

5.  Infectivity of ribonucleic acid from tobacco mosaic virus.

Authors:  A GIERER; G SCHRAMM
Journal:  Nature       Date:  1956-04-14       Impact factor: 49.962

6.  Ribonucleic acid in "transformation" of lymphoid cells.

Authors:  J A MANNICK; R H EGDAHL
Journal:  Science       Date:  1962-09-21       Impact factor: 47.728

7.  Ribonucleic acid-induced changes in mammalian cells.

Authors:  M C NIU; C C CORDOVA; L C NIU
Journal:  Proc Natl Acad Sci U S A       Date:  1961-10-15       Impact factor: 11.205

8.  The retention of S35-labelled bovine serum albumin in normal and immunized rabbit liver tissue.

Authors:  J S GARVEY; D H CAMPBELL
Journal:  J Exp Med       Date:  1957-04-01       Impact factor: 14.307

9.  Antibody formation in vitro.

Authors:  M FISHMAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

  9 in total
  74 in total

1.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

2.  DELAYED ANTIBODY SYNTHESIS IN MICE AFTER TRANSFER OF IMMUNE PERITONEAL FLUID CELLS.

Authors:  E WEILER
Journal:  Immunology       Date:  1964-05       Impact factor: 7.397

3.  TRANSFER OF HEIGHTENED IMMUNITY TO SKIN HOMOGRAFTS BY LYMPHOID RNA.

Authors:  J A MANNICK; R H EGDAHL
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

4.  QUANTITATIVE CELLULAR DISTRIBUTION OF TRITIATED ANTIGEN IN IMMUNIZED MICE.

Authors:  A N ROBERTS
Journal:  Am J Pathol       Date:  1964-03       Impact factor: 4.307

5.  INHIBITION BY RNA OF THE TRANSFER REACTION FOLLOWING HOMOGRAFT SENSITIZATION.

Authors:  J A MANNICK
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

6.  A THREE-CELL INTERACTION REQUIRED FOR THE INDUCTION OF THE PRIMARY IMMUNE RESPONSE in vitro.

Authors:  D E Mosier; L W Coppleson
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

7.  Detection and localization of aleutian disease virus and its antigens in vivo by immunoferritin technique.

Authors:  M S Shahrabadi; H J Cho
Journal:  Can J Comp Med       Date:  1977-10

8.  What history tells us XXXIV. The complex history of the selective model of antibody formation.

Authors:  Michel Morange
Journal:  J Biosci       Date:  2014-06       Impact factor: 1.826

9.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. IV. NORMAL ANTIBODY AND EARLY IMMUNE ANTIBODY OF RABBIT ORIGIN: A COMPARISON OF BIOLOGICAL AND PHYSICOCHEMICAL PROPERTIES.

Authors:  S E SVEHAG
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

Review 10.  Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.

Authors:  D Fritze; D H Kern; Y H Pilch
Journal:  Klin Wochenschr       Date:  1976-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.